Some specific supporting examples provided in a press release:
- In 2004, John McCain Co-Sponsored Bipartisan Drug Reimportation Legislation. “At a press conference today, Sen. Olympia J. Snowe (R-Maine) introduced breakthrough bipartisan, consensus prescription drug reimportation legislation, the Pharmaceutical Market Access and Drug Safety Act, with Sens. Byron Dorgan (D-ND), John McCain (R-AZ), Ted Kennedy (D-MA), Tom Daschle (D-SD), Trent Lott (R-MS) and Debbie Stabenow (D-MI).” (Sen. Olympia Snowe, Press Release, 4/21/04)
- A John McCain Bill To Make It Easier For Cheap Generic Drugs To Come Onto The Market Drew “Strong Opposition From The Pharmaceutical Industry.” “The most public front was active last week, with the Senate passing a bill intended to make it easier for cheap generic drugs to come onto the market. The bill, sponsored by Sens. Charles Schumer, D-N.Y., and John McCain, R-Ariz., drew considerable support in Congress and strong opposition from the pharmaceutical industry.” (“Insurers’ ‘Counter’ Attacks Aim To Boost Generic Drugs,” Grand Rapid Press, 8/11/02)
- John McCain Fought To Allow The Importation Of Cheaper Drugs Which Was “Adamantly Opposed By Industry Lobbyists.” “McCain said he wanted the government to be able to negotiate lower drug prices and import cheaper drugs from Canada, both ideas that were adamantly opposed by industry lobbyists, and which ultimately failed.” (Eamon Javers, “Is John McCain Good For Business?” Business Week Online, 2/7/08)
When both the GOP candidate and the Democratic candidate have the same message regarding Big Pharma and, specifically, Canadian pharmacies and drug reimportation, it should be obvious why the pharmaceutical industry and its proxies have become so desperate to change public opinion — by scaring the public into thinking licensed Canadian pharmacies are somehow dangerous.
We’re cautiously optimistic that, this time, their cynical tactics won’t work.32